pillbase.ru

Eribulin Baxter

Active substance: eribulin

Eribulin mesylate

Centralised EU authorisationActive

Marketing holder: Baxter Holding B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 17
  • ERIBULIN MESYLATE
    INJECTION · ERIBULIN MESYLATE .5 mg/mL
    40033-364
    Kindos Pharmaceuticals Co., Ltd.
  • ERIBULIN MESYLATE
    INJECTION · ERIBULIN MESYLATE .5 mg/mL
    39822-2080
    XGen Pharmaceuticals DJB, Inc.
  • ERIBULIN MESYLATE
    INJECTION · ERIBULIN MESYLATE .5 mg/mL
    70095-080
    Sun Pharmaceutical Industries Limited
  • ERIBULIN MESYLATE
    INJECTION · ERIBULIN MESYLATE .5 mg/mL
    0143-9167
    HIKMA PHARMACEUTICALS USA INC.
  • ERIBULIN MESYLATE
    INJECTION · ERIBULIN MESYLATE .5 mg/mL
    68462-770
    GLENMARK PHARMACEUTICALS INC., USA
All products in this country (17)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-5895-76e7-a2c1-e3ea26660d20,01a1208c-f5e5-76b5-9912-54859393b74e,01a1208d-1b5f-7ae9-8e8c-2e97b76b6695,01a1208d-63a9-7357-a60a-32a9df7935c2,01a1208d-84d4-74d7-b6d1-86da100ae078;count=17 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006191
Registration status
Active
ATC code
L01XX41
Sources
  • product · EMA · EMEA/H/C/006191 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006191 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006191 · Verified 2026-10-09